XBIT
XBiotech IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$77.44M
P/E Ratio
—
EPS
$-1.49
Beta
0.83
52W High
$3.61
52W Low
$2.09
50-Day MA
$2.37
200-Day MA
$2.58
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 300,000 |
| Gross Profit (TTM) | $3.36M |
| EBITDA | $-54.00M |
| Operating Margin | 0.00% |
| Return on Equity | -28.20% |
| Return on Assets | -19.90% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $4.60 |
| Price-to-Book | 0.55 |
| Price-to-Sales (TTM) | 12.23 |
| EV/Revenue | 24.05 |
| EV/EBITDA | -1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -93.30% |
| Shares Outstanding | $30.49M |
| Float | $19.09M |
| % Insiders | 36.61% |
| % Institutions | 7.69% |
Historical Volatility
HV 10-Day
21.47%
HV 20-Day
22.08%
HV 30-Day
26.12%
HV 60-Day
32.51%
HV Rank
1.6%
Volatility is currently contracting
Data last updated: 4/29/2026